| |
| |
|
| Insider
Information: |
Neylan John F. |
| Relationship: |
See Remarks |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
35,136 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,136 |
|
|
| Total
Value |
$35,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -82.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Medical Officer |
2018-12-12 |
0 |
|
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
See Remarks |
2021-12-20 |
35,136 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical OfficerOfficer |
• – – |
2015-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,000 |
|
- |
|
| ELTX |
Elicio Therapeutics Ord S... |
See RemarksOfficer |
• – – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,895 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2015-08-12 |
4 |
B |
$6.20 |
$62,000 |
D/D |
10,000 |
55,000 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
53,750 |
98,750 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2016-04-25 |
4 |
S |
$5.21 |
$24,831 |
D/D |
(4,766) |
93,984 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2016-07-25 |
4 |
S |
$7.43 |
$9,042 |
D/D |
(1,217) |
92,767 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2016-10-24 |
4 |
S |
$4.72 |
$5,716 |
D/D |
(1,211) |
91,556 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-01-23 |
4 |
S |
$5.39 |
$7,697 |
D/D |
(1,428) |
90,128 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-01-30 |
4 |
S |
$4.65 |
$32,476 |
D/D |
(6,984) |
83,144 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
131,894 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-04-24 |
4 |
S |
$5.73 |
$6,928 |
D/D |
(1,209) |
130,685 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
129,244 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-07-24 |
4 |
S |
$7.27 |
$8,826 |
D/D |
(1,214) |
128,030 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-07-31 |
4 |
S |
$7.14 |
$10,317 |
D/D |
(1,445) |
126,585 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-10-23 |
4 |
S |
$6.53 |
$7,699 |
D/D |
(1,179) |
125,406 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-10-30 |
4 |
S |
$6.03 |
$8,472 |
D/D |
(1,405) |
124,001 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-01-23 |
4 |
S |
$4.92 |
$6,504 |
D/D |
(1,322) |
122,679 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-01-29 |
4 |
S |
$4.81 |
$7,412 |
D/D |
(1,541) |
121,138 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-02-15 |
4 |
S |
$4.81 |
$27,186 |
D/D |
(5,652) |
115,486 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
41,250 |
156,736 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-04-23 |
4 |
S |
$4.59 |
$5,099 |
D/D |
(1,111) |
155,625 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-04-30 |
4 |
S |
$4.67 |
$6,122 |
D/D |
(1,311) |
154,314 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-05-15 |
4 |
S |
$5.69 |
$6,589 |
D/D |
(1,158) |
153,156 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-07-30 |
4 |
S |
$3.86 |
$4,949 |
D/D |
(1,282) |
151,874 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-08-15 |
4 |
S |
$3.04 |
$3,605 |
D/D |
(1,186) |
150,688 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
